175 related articles for article (PubMed ID: 11895215)
1. Low individualized growth hormone (GH) dose increased renal and cardiac growth in young adults with childhood onset GH deficiency.
Link K; Bülow B; Westman K; Salmonsson EC; Eskilsson J; Erfurth EM
Clin Endocrinol (Oxf); 2001 Dec; 55(6):741-8. PubMed ID: 11895215
[TBL] [Abstract][Full Text] [Related]
2. Body composition and quality of life in adults with growth hormone deficiency; effects of low-dose growth hormone replacement.
Ahmad AM; Hopkins MT; Thomas J; Ibrahim H; Fraser WD; Vora JP
Clin Endocrinol (Oxf); 2001 Jun; 54(6):709-17. PubMed ID: 11422104
[TBL] [Abstract][Full Text] [Related]
3. Three weekly injections (TWI) of low-dose growth hormone (GH) restore low normal circulating IGF-I concentrations and reverse cardiac abnormalities associated with adult onset GH deficiency (GHD).
Pincelli AI; Bragato R; Scacchi M; Branzi G; Osculati G; Viarengo R; Leonetti G; Cavagnini F
J Endocrinol Invest; 2003 May; 26(5):420-8. PubMed ID: 12906369
[TBL] [Abstract][Full Text] [Related]
4. A low individualized GH dose in young patients with childhood onset GH deficiency normalized serum IGF-I without significant deterioration in glucose tolerance.
Bülow B; Erfurth EM
Clin Endocrinol (Oxf); 1999 Jan; 50(1):45-55. PubMed ID: 10341855
[TBL] [Abstract][Full Text] [Related]
5. The influence of growth hormone therapy on ultrasound myocardial tissue characterization in patients with childhood onset GH deficiency.
Minczykowski A; Gryczynska M; Ziemnicka K; Sowinski J; Wysocki H
Int J Cardiol; 2005 May; 101(2):257-63. PubMed ID: 15882673
[TBL] [Abstract][Full Text] [Related]
6. The influence of growth hormone (GH) therapy on cardiac performance in patients with childhood onset GH deficiency.
Minczykowski A; Gryczynska M; Ziemnicka K; Czepczynski R; Sowinski J; Wysocki H
Growth Horm IGF Res; 2005 Apr; 15(2):156-64. PubMed ID: 15809020
[TBL] [Abstract][Full Text] [Related]
7. Monitoring serum insulin-like growth factor-I (IGF-I), IGF binding protein-3 (IGFBP-3), IGF-I/IGFBP-3 molar ratio and leptin during growth hormone treatment for disordered growth.
Tillmann V; Patel L; Gill MS; Whatmore AJ; Price DA; Kibirige MS; Wales JK; Clayton PE
Clin Endocrinol (Oxf); 2000 Sep; 53(3):329-36. PubMed ID: 10971450
[TBL] [Abstract][Full Text] [Related]
8. A low starting dose of genotropin in growth hormone-deficient adults.
Janssen YJ; Frölich M; Roelfsema F
J Clin Endocrinol Metab; 1997 Jan; 82(1):129-35. PubMed ID: 8989246
[TBL] [Abstract][Full Text] [Related]
9. The impact of idiopathic childhood-onset growth hormone deficiency (GHD) on bone mass in subjects without adult GHD.
Lange M; Müller J; Svendsen OL; Kastrup KW; Juul A; Feldt-Rasmussen U
Clin Endocrinol (Oxf); 2005 Jan; 62(1):18-23. PubMed ID: 15638865
[TBL] [Abstract][Full Text] [Related]
10. Influences on quality of life in GH deficient adults and their effect on response to treatment.
Murray RD; Skillicorn CJ; Howell SJ; Lissett CA; Rahim A; Smethurst LE; Shalet SM
Clin Endocrinol (Oxf); 1999 Nov; 51(5):565-73. PubMed ID: 10594517
[TBL] [Abstract][Full Text] [Related]
11. Pre-treatment IGF-I level is the major determinant of GH dosage in adult GH deficiency.
Murray RD; Howell SJ; Lissett CA; Shalet SM
Clin Endocrinol (Oxf); 2000 May; 52(5):537-42. PubMed ID: 10792331
[TBL] [Abstract][Full Text] [Related]
12. The cardiovascular risk of GH-deficient adolescents.
Colao A; Di Somma C; Salerno M; Spinelli L; Orio F; Lombardi G
J Clin Endocrinol Metab; 2002 Aug; 87(8):3650-5. PubMed ID: 12161490
[TBL] [Abstract][Full Text] [Related]
13. Growth hormone versus placebo treatment for one year in growth hormone deficient adults: increase in exercise capacity and normalization of body composition.
Jørgensen JO; Vahl N; Hansen TB; Thuesen L; Hagen C; Christiansen JS
Clin Endocrinol (Oxf); 1996 Dec; 45(6):681-8. PubMed ID: 9039333
[TBL] [Abstract][Full Text] [Related]
14. Beneficial effects of growth hormone treatment in GH-deficient adults.
Jørgensen JO; Pedersen SA; Thuesen L; Jørgensen J; Ingemann-Hansen T; Skakkebaek NE; Christiansen JS
Lancet; 1989 Jun; 1(8649):1221-5. PubMed ID: 2566779
[TBL] [Abstract][Full Text] [Related]
15. Two years of replacement therapy in adults with growth hormone deficiency.
Verhelst J; Abs R; Vandeweghe M; Mockel J; Legros JJ; Copinschi G; Mahler C; Velkeniers B; Vanhaelst L; Van Aelst A; De Rijdt D; Stevenaert A; Beckers A
Clin Endocrinol (Oxf); 1997 Oct; 47(4):485-94. PubMed ID: 9404448
[TBL] [Abstract][Full Text] [Related]
16. Cardiac dimension and function in patients with childhood onset growth hormone deficiency, before and after growth hormone retreatment in adult age.
Feinberg MS; Scheinowitz M; Laron Z
Am Heart J; 2003 Mar; 145(3):549-53. PubMed ID: 12660681
[TBL] [Abstract][Full Text] [Related]
17. Growth hormone (GH) dose-response in young adults with childhood-onset GH deficiency: a two-year, multicenter, multiple-dose, placebo-controlled study.
Underwood LE; Attie KM; Baptista J;
J Clin Endocrinol Metab; 2003 Nov; 88(11):5273-80. PubMed ID: 14602761
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).
Chihara K; Kato Y; Kohno H; Takano K; Tanaka T; Teramoto A; Shimatsu A
Growth Horm IGF Res; 2008 Aug; 18(4):307-17. PubMed ID: 18282776
[TBL] [Abstract][Full Text] [Related]
19. Comparison of continuation or cessation of growth hormone (GH) therapy on body composition and metabolic status in adolescents with severe GH deficiency at completion of linear growth.
Carroll PV; Drake WM; Maher KT; Metcalfe K; Shaw NJ; Dunger DB; Cheetham TD; Camacho-Hübner C; Savage MO; Monson JP
J Clin Endocrinol Metab; 2004 Aug; 89(8):3890-5. PubMed ID: 15292323
[TBL] [Abstract][Full Text] [Related]
20. Impaired cardiac performance in elderly patients with growth hormone deficiency.
Colao A; Cuocolo A; Di Somma C; Cerbone G; Della Morte AM; Nicolai E; Lucci R; Salvatore M; Lombardi G
J Clin Endocrinol Metab; 1999 Nov; 84(11):3950-5. PubMed ID: 10566633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
